Is Bloom Energy The Best Stock to Buy Now?
Shares of energy startup Bloom Energy (NYSE:BE) have advanced by…
Sell
40
SENS Quote, Financials, Valuation and Earnings
Last price:
$6.16
Seasonality move
:
65.68%
Day range:
$6.03 - $6.35
52-week range:
$5.25 - $28.00
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
73.46x
P/B ratio:
3.21x
Volume:
1.1M
Avg. volume:
414.8K
1-year change:
-30.43%
Market cap:
$250.9M
Revenue:
$22.5M
EPS (TTM):
-$1.33
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
SENS
Senseonics Holdings, Inc.
|
$7.9M | -$0.40 | 71.77% | -15.83% | $18.92 |
|
CATX
Perspective Therapeutics, Inc.
|
$147K | -$0.35 | -9.65% | -37.91% | $12.3077 |
|
DXCM
DexCom, Inc.
|
$1.2B | $0.47 | 11.43% | 70.3% | $85.27 |
|
INSP
Inspire Medical Systems, Inc.
|
$213.4M | $0.12 | 9.49% | -40.88% | $140.00 |
|
PODD
Insulet Corp.
|
$714.4M | $1.19 | 28.59% | 5.4% | $377.72 |
|
TNDM
Tandem Diabetes Care, Inc.
|
$248.8M | -$0.42 | -2.05% | -4.07% | $24.81 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
SENS
Senseonics Holdings, Inc.
|
$6.15 | $18.92 | $250.9M | -- | $0.00 | 0% | 73.46x |
|
CATX
Perspective Therapeutics, Inc.
|
$2.7500 | $12.3077 | $204.4M | -- | $0.00 | 0% | 186.46x |
|
DXCM
DexCom, Inc.
|
$66.06 | $85.27 | $25.8B | 36.77x | $0.00 | 0% | 5.96x |
|
INSP
Inspire Medical Systems, Inc.
|
$96.54 | $140.00 | $2.8B | 66.22x | $0.00 | 0% | 3.29x |
|
PODD
Insulet Corp.
|
$289.62 | $377.72 | $20.4B | 84.03x | $0.00 | 0% | 8.31x |
|
TNDM
Tandem Diabetes Care, Inc.
|
$22.07 | $24.81 | $1.5B | -- | $0.00 | 0% | 1.46x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
SENS
Senseonics Holdings, Inc.
|
34.5% | -1.340 | 11.59% | 5.67x |
|
CATX
Perspective Therapeutics, Inc.
|
1.35% | 3.691 | 1.3% | 8.47x |
|
DXCM
DexCom, Inc.
|
48.58% | 1.694 | 9.81% | 1.33x |
|
INSP
Inspire Medical Systems, Inc.
|
4.66% | -0.876 | 1.51% | 3.89x |
|
PODD
Insulet Corp.
|
42.7% | 1.380 | 4.75% | 1.89x |
|
TNDM
Tandem Diabetes Care, Inc.
|
77.16% | 1.243 | 54.61% | 1.79x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
SENS
Senseonics Holdings, Inc.
|
$3.5M | -$19.6M | -64.5% | -127.71% | -242.14% | -$16.4M |
|
CATX
Perspective Therapeutics, Inc.
|
-$566K | -$27.9M | -37.13% | -37.63% | -13330.62% | -$18.3M |
|
DXCM
DexCom, Inc.
|
$747.4M | $242.5M | 14.67% | 30.94% | 20.05% | $579.4M |
|
INSP
Inspire Medical Systems, Inc.
|
$192.7M | $9.6M | 6.32% | 6.62% | 4.3% | $58.1M |
|
PODD
Insulet Corp.
|
$513.5M | $117.7M | 9.14% | 18.92% | 16.66% | $94.6M |
|
TNDM
Tandem Diabetes Care, Inc.
|
$134.3M | -$20.1M | -31.16% | -110.24% | -8.05% | $4.2M |
Senseonics Holdings, Inc. vs. Competitors
-
Which has Higher Returns SENS or CATX?
Perspective Therapeutics, Inc. has a net margin of -241.26% compared to Senseonics Holdings, Inc.'s net margin of -12425.36%. Senseonics Holdings, Inc.'s return on equity of -127.71% beat Perspective Therapeutics, Inc.'s return on equity of -37.63%.
Company Gross Margin Earnings Per Share Invested Capital SENSSenseonics Holdings, Inc.42.84% -$0.43 $119.3M CATXPerspective Therapeutics, Inc.-270.81% -$0.35 $245.5M -
What do Analysts Say About SENS or CATX?
Senseonics Holdings, Inc. has a consensus price target of $18.92, signalling upside risk potential of 207.59%. On the other hand Perspective Therapeutics, Inc. has an analysts' consensus of $12.3077 which suggests that it could grow by 347.55%. Given that Perspective Therapeutics, Inc. has higher upside potential than Senseonics Holdings, Inc., analysts believe Perspective Therapeutics, Inc. is more attractive than Senseonics Holdings, Inc..
Company Buy Ratings Hold Ratings Sell Ratings SENSSenseonics Holdings, Inc.3 2 0 CATXPerspective Therapeutics, Inc.12 1 0 -
Is SENS or CATX More Risky?
Senseonics Holdings, Inc. has a beta of 0.922, which suggesting that the stock is 7.793% less volatile than S&P 500. In comparison Perspective Therapeutics, Inc. has a beta of 1.222, suggesting its more volatile than the S&P 500 by 22.249%.
-
Which is a Better Dividend Stock SENS or CATX?
Senseonics Holdings, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Perspective Therapeutics, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Senseonics Holdings, Inc. pays -- of its earnings as a dividend. Perspective Therapeutics, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios SENS or CATX?
Senseonics Holdings, Inc. quarterly revenues are $8.1M, which are larger than Perspective Therapeutics, Inc. quarterly revenues of $209K. Senseonics Holdings, Inc.'s net income of -$19.5M is higher than Perspective Therapeutics, Inc.'s net income of -$26M. Notably, Senseonics Holdings, Inc.'s price-to-earnings ratio is -- while Perspective Therapeutics, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Senseonics Holdings, Inc. is 73.46x versus 186.46x for Perspective Therapeutics, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income SENSSenseonics Holdings, Inc.73.46x -- $8.1M -$19.5M CATXPerspective Therapeutics, Inc.186.46x -- $209K -$26M
-
Which has Higher Returns SENS or DXCM?
DexCom, Inc. has a net margin of -241.26% compared to Senseonics Holdings, Inc.'s net margin of 23.47%. Senseonics Holdings, Inc.'s return on equity of -127.71% beat DexCom, Inc.'s return on equity of 30.94%.
Company Gross Margin Earnings Per Share Invested Capital SENSSenseonics Holdings, Inc.42.84% -$0.43 $119.3M DXCMDexCom, Inc.61.8% $0.70 $5.3B -
What do Analysts Say About SENS or DXCM?
Senseonics Holdings, Inc. has a consensus price target of $18.92, signalling upside risk potential of 207.59%. On the other hand DexCom, Inc. has an analysts' consensus of $85.27 which suggests that it could grow by 29.08%. Given that Senseonics Holdings, Inc. has higher upside potential than DexCom, Inc., analysts believe Senseonics Holdings, Inc. is more attractive than DexCom, Inc..
Company Buy Ratings Hold Ratings Sell Ratings SENSSenseonics Holdings, Inc.3 2 0 DXCMDexCom, Inc.20 4 0 -
Is SENS or DXCM More Risky?
Senseonics Holdings, Inc. has a beta of 0.922, which suggesting that the stock is 7.793% less volatile than S&P 500. In comparison DexCom, Inc. has a beta of 1.513, suggesting its more volatile than the S&P 500 by 51.265%.
-
Which is a Better Dividend Stock SENS or DXCM?
Senseonics Holdings, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. DexCom, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Senseonics Holdings, Inc. pays -- of its earnings as a dividend. DexCom, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios SENS or DXCM?
Senseonics Holdings, Inc. quarterly revenues are $8.1M, which are smaller than DexCom, Inc. quarterly revenues of $1.2B. Senseonics Holdings, Inc.'s net income of -$19.5M is lower than DexCom, Inc.'s net income of $283.8M. Notably, Senseonics Holdings, Inc.'s price-to-earnings ratio is -- while DexCom, Inc.'s PE ratio is 36.77x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Senseonics Holdings, Inc. is 73.46x versus 5.96x for DexCom, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income SENSSenseonics Holdings, Inc.73.46x -- $8.1M -$19.5M DXCMDexCom, Inc.5.96x 36.77x $1.2B $283.8M
-
Which has Higher Returns SENS or INSP?
Inspire Medical Systems, Inc. has a net margin of -241.26% compared to Senseonics Holdings, Inc.'s net margin of 4.42%. Senseonics Holdings, Inc.'s return on equity of -127.71% beat Inspire Medical Systems, Inc.'s return on equity of 6.62%.
Company Gross Margin Earnings Per Share Invested Capital SENSSenseonics Holdings, Inc.42.84% -$0.43 $119.3M INSPInspire Medical Systems, Inc.85.85% $0.34 $699M -
What do Analysts Say About SENS or INSP?
Senseonics Holdings, Inc. has a consensus price target of $18.92, signalling upside risk potential of 207.59%. On the other hand Inspire Medical Systems, Inc. has an analysts' consensus of $140.00 which suggests that it could grow by 45.02%. Given that Senseonics Holdings, Inc. has higher upside potential than Inspire Medical Systems, Inc., analysts believe Senseonics Holdings, Inc. is more attractive than Inspire Medical Systems, Inc..
Company Buy Ratings Hold Ratings Sell Ratings SENSSenseonics Holdings, Inc.3 2 0 INSPInspire Medical Systems, Inc.9 6 0 -
Is SENS or INSP More Risky?
Senseonics Holdings, Inc. has a beta of 0.922, which suggesting that the stock is 7.793% less volatile than S&P 500. In comparison Inspire Medical Systems, Inc. has a beta of 0.696, suggesting its less volatile than the S&P 500 by 30.412%.
-
Which is a Better Dividend Stock SENS or INSP?
Senseonics Holdings, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Inspire Medical Systems, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Senseonics Holdings, Inc. pays -- of its earnings as a dividend. Inspire Medical Systems, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios SENS or INSP?
Senseonics Holdings, Inc. quarterly revenues are $8.1M, which are smaller than Inspire Medical Systems, Inc. quarterly revenues of $224.5M. Senseonics Holdings, Inc.'s net income of -$19.5M is lower than Inspire Medical Systems, Inc.'s net income of $9.9M. Notably, Senseonics Holdings, Inc.'s price-to-earnings ratio is -- while Inspire Medical Systems, Inc.'s PE ratio is 66.22x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Senseonics Holdings, Inc. is 73.46x versus 3.29x for Inspire Medical Systems, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income SENSSenseonics Holdings, Inc.73.46x -- $8.1M -$19.5M INSPInspire Medical Systems, Inc.3.29x 66.22x $224.5M $9.9M
-
Which has Higher Returns SENS or PODD?
Insulet Corp. has a net margin of -241.26% compared to Senseonics Holdings, Inc.'s net margin of 12.4%. Senseonics Holdings, Inc.'s return on equity of -127.71% beat Insulet Corp.'s return on equity of 18.92%.
Company Gross Margin Earnings Per Share Invested Capital SENSSenseonics Holdings, Inc.42.84% -$0.43 $119.3M PODDInsulet Corp.72.7% $1.24 $2.4B -
What do Analysts Say About SENS or PODD?
Senseonics Holdings, Inc. has a consensus price target of $18.92, signalling upside risk potential of 207.59%. On the other hand Insulet Corp. has an analysts' consensus of $377.72 which suggests that it could grow by 30.42%. Given that Senseonics Holdings, Inc. has higher upside potential than Insulet Corp., analysts believe Senseonics Holdings, Inc. is more attractive than Insulet Corp..
Company Buy Ratings Hold Ratings Sell Ratings SENSSenseonics Holdings, Inc.3 2 0 PODDInsulet Corp.19 2 0 -
Is SENS or PODD More Risky?
Senseonics Holdings, Inc. has a beta of 0.922, which suggesting that the stock is 7.793% less volatile than S&P 500. In comparison Insulet Corp. has a beta of 1.374, suggesting its more volatile than the S&P 500 by 37.428%.
-
Which is a Better Dividend Stock SENS or PODD?
Senseonics Holdings, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Insulet Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Senseonics Holdings, Inc. pays -- of its earnings as a dividend. Insulet Corp. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios SENS or PODD?
Senseonics Holdings, Inc. quarterly revenues are $8.1M, which are smaller than Insulet Corp. quarterly revenues of $706.3M. Senseonics Holdings, Inc.'s net income of -$19.5M is lower than Insulet Corp.'s net income of $87.6M. Notably, Senseonics Holdings, Inc.'s price-to-earnings ratio is -- while Insulet Corp.'s PE ratio is 84.03x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Senseonics Holdings, Inc. is 73.46x versus 8.31x for Insulet Corp.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income SENSSenseonics Holdings, Inc.73.46x -- $8.1M -$19.5M PODDInsulet Corp.8.31x 84.03x $706.3M $87.6M
-
Which has Higher Returns SENS or TNDM?
Tandem Diabetes Care, Inc. has a net margin of -241.26% compared to Senseonics Holdings, Inc.'s net margin of -8.49%. Senseonics Holdings, Inc.'s return on equity of -127.71% beat Tandem Diabetes Care, Inc.'s return on equity of -110.24%.
Company Gross Margin Earnings Per Share Invested Capital SENSSenseonics Holdings, Inc.42.84% -$0.43 $119.3M TNDMTandem Diabetes Care, Inc.53.88% -$0.31 $582.2M -
What do Analysts Say About SENS or TNDM?
Senseonics Holdings, Inc. has a consensus price target of $18.92, signalling upside risk potential of 207.59%. On the other hand Tandem Diabetes Care, Inc. has an analysts' consensus of $24.81 which suggests that it could grow by 12.41%. Given that Senseonics Holdings, Inc. has higher upside potential than Tandem Diabetes Care, Inc., analysts believe Senseonics Holdings, Inc. is more attractive than Tandem Diabetes Care, Inc..
Company Buy Ratings Hold Ratings Sell Ratings SENSSenseonics Holdings, Inc.3 2 0 TNDMTandem Diabetes Care, Inc.7 13 0 -
Is SENS or TNDM More Risky?
Senseonics Holdings, Inc. has a beta of 0.922, which suggesting that the stock is 7.793% less volatile than S&P 500. In comparison Tandem Diabetes Care, Inc. has a beta of 1.685, suggesting its more volatile than the S&P 500 by 68.536%.
-
Which is a Better Dividend Stock SENS or TNDM?
Senseonics Holdings, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Tandem Diabetes Care, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Senseonics Holdings, Inc. pays -- of its earnings as a dividend. Tandem Diabetes Care, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios SENS or TNDM?
Senseonics Holdings, Inc. quarterly revenues are $8.1M, which are smaller than Tandem Diabetes Care, Inc. quarterly revenues of $249.3M. Senseonics Holdings, Inc.'s net income of -$19.5M is higher than Tandem Diabetes Care, Inc.'s net income of -$21.2M. Notably, Senseonics Holdings, Inc.'s price-to-earnings ratio is -- while Tandem Diabetes Care, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Senseonics Holdings, Inc. is 73.46x versus 1.46x for Tandem Diabetes Care, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income SENSSenseonics Holdings, Inc.73.46x -- $8.1M -$19.5M TNDMTandem Diabetes Care, Inc.1.46x -- $249.3M -$21.2M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Berkshire Hathaway Stock Undervalued?
Berkshire Hathaway (NYSE:BRK.A,BRK.B) has undershot the market this year, returning…
Is Oracle Stock Undervalued?
Shares of Oracle (NYSE:ORCL) rocketed higher earlier this year when…
Stock Ideas
Buy
54
Is NVDA Stock a Buy?
Market Cap: $4.4T
P/E Ratio: 62x
Buy
53
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
57
Is GOOG Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 38x
Alerts
Sell
1
LW alert for Dec 20
Lamb Weston Holdings, Inc. [LW] is down 25.96% over the past day.
Buy
54
BMRN alert for Dec 20
BioMarin Pharmaceutical, Inc. [BMRN] is up 17.79% over the past day.
Buy
82
RKLB alert for Dec 20
Rocket Lab Corp. [RKLB] is up 17.72% over the past day.
